Contineum Therapeutics Ratios (2023-2026) | CTNM

Ratios Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Profitability
EBT Margin (Quarter) 84.60%
EBIT Margin (Quarter) 77.87%
EBITDA Margin (Quarter) 83.02%
Operating Margin (Quarter) 77.87%
Net Margin (Quarter) 83.20%
FCF Margin (Quarter) 81.29%
Efficiency
Assets Average (Quarter) 126.97M172.46M218.69M214.44M205.56M190.58M186.87M233.74M269.00M
Equity Average (Quarter) -76.45M-58.29M-64.54M-71.78M70.94M213.87M204.15M191.42M178.08M175.93M220.73M255.51M
Invested Capital (Quarter) -97.46M-55.43M-61.15M-67.94M-75.63M217.50M210.23M198.07M184.77M171.39M180.47M260.99M250.04M
Asset Utilization Ratio (Quarter) 0.29
Leverage & Solvency
Interest Coverage Ratio (Quarter) -55.60335.66
Equity Ratio (Quarter) -0.52-0.610.980.970.930.930.940.950.940.96
Times Interest Earned (Quarter) -55.60335.66
Valuation
Enterprise Value (Quarter) -125.19M-117.91M-218.65M-213.91M-204.76M-190.71M-175.48M-182.41M-262.90M-246.33M
Return Ratios
Return on Sales (Quarter) 0.01%-0.01%
Return on Capital Employed (Quarter) 0.06%-29.52%-25.70%-24.89%-30.05%-36.01%-37.67%-30.38%-25.48%
Return on Invested Capital (Quarter) 0.00%0.00%-0.01%0.00%
Return on Assets (Quarter) 0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Return on Equity (Quarter) 0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%